Table of Contents Table of Contents
Previous Page  149 / 220 Next Page
Information
Show Menu
Previous Page 149 / 220 Next Page
Page Background

The Laryngoscope

V

C

2016 The American Laryngological,

Rhinological and Otological Society, Inc.

Factors That Impact Health-Related Quality of Life Over

Time for Individuals With Head and Neck Cancer

Bryce B. Reeve, PhD; Jianwen Cai, PhD; Hongtao Zhang, PhD; Mark C. Weissler, MD;

Kathy Wisniewski, BS; Heather Gross, MEd; Andrew F. Olshan, PhD

Objectives/Hypothesis:

To identify sociodemographic, behavioral, and clinical factors associated with health-related

quality of life (HRQOL) for head and neck cancer (HNC) patients over time.

Study Design:

A population-based longitudinal cohort study.

Methods:

Newly diagnosed HNC patients (N

5

587) were administered the Functional Assessment of Cancer Therapy–

Head and Neck questionnaire at baseline (median 3 months postdiagnosis) and two follow-up assessments (median 22 and

42 months). Linear mixed-effect models were used with backward variable selection to identify factors associated with HRQOL

over time (

P

<

.05). Adjusted means reported at 2 years postdiagnosis.

Results:

African Americans reported better Functional Well-Being than whites (mean of 20.01 vs. 18.53) and fewer HNC

symptoms over time. Older patients (75

1

years) reported better HRQOL than younger patients (

<

50 years). Current tobacco

use compared to no tobacco use had worse Physical (20.20 vs. 21.50), Emotional (17.55 vs. 19.06), Social (21.28 vs. 22.88),

and Functional (17.32 vs. 19.29) Well-Being and more HNC symptoms (21.50 vs. 23.71). Radiation therapy was associated

with worse Physical and Functional Well-Being and more head and neck symptoms over time, but HRQOL was similar to

those who were not irradiated by 2 to 4 years postdiagnosis.

Conclusion:

This study identified key factors for individuals at risk for poorer HRQOL that may help clinicians and caregiv-

ers find solutions to address these decrements. Smoking cessation programs can be encouraged for survivors who use tobacco.

Psychological and social support and medications may help for dealing with emotional distress and dealing with the physical

symptoms from treatment.

Key Words:

Health-related quality of life, symptoms, head and neck cancer, radiation therapy, longitudinal study.

Level of Evidence:

4.

Laryngoscope

, 00:000–000, 2016

INTRODUCTION

Overall, the incidence of head and neck cancer

(HNC) (oral cavity, pharynx, larynx) began decreasing in

about 1991 but has stabilized since about 2003.

1

In

2015, an estimated 59,340 individuals in the United

States were diagnosed, and approximately 12,290 died

from a HNC.

2

Incidence rates are twice as high in men

as women. Incidence rates in African Americans have

also declined over the past two decades and are cur-

rently lower than in non-Hispanic whites. The standard

for treating HNC has been surgery; however, since the

early 1990s there has been an increase in the use of pri-

mary radiation and chemotherapy.

3,4

This has been par-

tially driven by the increase in the number of human

papilloma virus (HPV)-associated oropharyngeal cancers.

Both the cancer and its treatment can have pro-

found effects on an individual’s health-related quality of

life (HRQOL). Physically, they may experience facial dis-

figurement and problems with eating, breathing, and

speaking.

5

Mentally, they may experience negative body

image, depression, anxiety, and fatigue.

5–8

Socially, they

may experience impaired communication, disrupted

social relationships, social isolation, stigmatism, and

work impairment.

5,9

Although some symptoms improve

over time after treatment, some HRQOL decrements

persist, including functional limitations and psychosocial

impact.

5,9

Several factors have been found to be associated

with HRQOL in HNCs. Behavioral factors include use of

tobacco

10–15

and alcohol.

16–20

Sociodemographic variables

include age,

9,13,21,22

race,

23

education,

13,18

and employ-

ment status.

9

Clinical factors include disease stage and

the use of radiation therapy.

9,24–31

However, much of the

literature is either more than 10 years old, based on

small sample sizes, or shows no or conflicting relation-

ships with HRQOL.

This study builds on a previous published study of

the HRQOL of individuals receiving care for HNC in

From the Department of Health Policy and Management (

B

.

B

.

R

.);

the Department of Biostatistics (

J

.

C

.,

H

.

Z

.); the Department of Epidemiology

(

K

.

W

.,

A

.

F

.

O

.), Gillings School of Global Public Health; the Lineberger Com-

prehensive Cancer Center (

B

.

B

.

R

.,

A

.

F

.

O

.); the Sheps Health Services

Research Center (

B

.

B

.

R

.,

H

.

G

.); and the Department of Otolaryngology–

Head & Neck Surgery (

M

.

C

.

W

.,

A

.

F

.

O

.), University of North Carolina at

Chapel Hill, Chapel Hill, North Carolina, U.S.A.

Editor’s Note: This Manuscript was accepted for publication April

6, 2016.

This study was funded by a grant from the Lance Armstrong Foun-

dation and in part by the National Cancer Institute (R01-CA90731). The

authors have no other funding, financial relationships, or conflicts of

interest to disclose.

Send correspondence to Bryce B. Reeve, PhD, University of North

Carolina at Chapel Hill, 1101-D McGavran-Greenberg Building, 135

Dauer Drive, CB 7411, Chapel Hill, NC 27599-7411.

E-mail:

bbreeve@email.UNC.edu

DOI: 10.1002/lary.26073

Reeve et al.: Factors Associated With Quality of Life

Reprinted by permission of Laryngoscope. 2016; 126(12):2718-2725.

129